about
Interventions for actinic keratosesBasal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical TherapiesMolecular cancer prevention: Current status and future directionsHow to treat actinic keratosis? An updateDiscovery of Anticancer Agents of Diverse Natural OriginRasGRPs are targets of the anti-cancer agent ingenol-3-angelateIngenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin CancersTattoo removal with ingenol mebutate.Actinic keratosis: rationale and managementActinic keratosis modelling in mice: A translational study.Trial Watch: Toll-like receptor agonists in oncological indications.Advances in the management of cutaneous squamous cell carcinoma.Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.Pharmacotherapy of actinic keratosis: an update.Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.Actinic keratosis: update on field therapy.Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosisTolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropePrimary care review of actinic keratosis and its therapeutic options: a global perspectiveAblative fractional laser alters biodistribution of ingenol mebutate in the skin.Cost-utility of first-line actinic keratosis treatments in FinlandMethods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments.IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.Laser assisted Drug Delivery: Grundlagen und Praxis.Laser-assisted drug delivery: mode of action and use in daily clinical practice.Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice.New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.The role of ingenol mebutate in the treatment of actinic keratoses.Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 miceOptimal treatment of actinic keratoses.In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 PatientsDermoscopy and Reflectance Confocal Microscopy for Monitoring the Treatment of Actinic Keratosis with Ingenol Mebutate Gel: Report of Two CasesDoubly blind: a systematic review of gender in randomised controlled trials.Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
P2860
Q24202407-6077B24D-4995-4A86-9752-E97B6AED02BAQ26744173-089322B7-F1C6-48CF-9FA6-3A2867AA52C6Q26797207-6929729B-E731-49AE-830A-3AE38C321284Q26799944-01DFAC09-500C-4F29-8A03-00C33DA10DA7Q28068341-FBA6ECF9-EDF2-45A9-8817-FFC88CC294FBQ28535474-A39CF98B-9623-4E33-8AB1-30F322EB827CQ28820706-168CB546-E359-48F4-9500-92DA9BC43D52Q33739024-351803B2-B10D-434D-89EF-4B92A071C692Q33785049-D94B0D58-E481-4567-8CBF-577F4A82380AQ33853271-BAEF2021-4DF7-48D2-A94D-0EFF8F6595E6Q33878578-AA1E3DB3-AD43-487F-B490-FEBB20EABBB9Q34019942-AB7244D2-15F7-4864-87D0-4599A1965447Q34299210-0D677448-1EBC-44D2-983B-DDFE759B4240Q34336675-0BA691D8-5A3E-4462-8D2F-14F9744D2F07Q34378153-E60E4FD0-4D5D-40B8-A27C-6B3CB6EB241AQ34381303-574C9DF4-85CE-405D-AFAD-D0A65CA4732FQ34441431-FC5FC991-2DAC-48ED-B786-0D91CB49C2A7Q34757193-71389162-61D5-400E-AB51-D40EAD3D549EQ34846964-6D499C52-BD55-42E7-B99B-69BC60DF71F1Q35115492-21781DC8-4A78-4C83-B702-3EAA1616A4F3Q35180653-1D2EB338-795E-4BE7-86D8-A702A17E3154Q35217907-3B3336A9-2839-4B58-B23E-0C5D6D9E0703Q35592491-A405F682-CCEE-42AA-9EC0-3BA521C96040Q35666250-633E7BA7-BB7A-4518-9ACD-4525301A695EQ35767304-22FA2B7C-3149-4CD8-8030-171854C14666Q35906874-1A2EF804-C4ED-4711-A8AD-87F742286634Q35996041-23F9F712-5640-4257-92BA-BE8CDC67D7B8Q36000662-A326CCA2-086E-4EA8-8D16-6F98E7115C6AQ36000667-355FF79D-661C-4C08-A9B2-E71A4226499DQ36128569-ED33F1FB-AACF-4D13-9650-3E0C12D90C77Q36135774-2AC8E1CA-274F-4CC8-9DDD-A8F3B92558FAQ36196699-F2100031-C6DF-4A93-9C63-7C1D5F0369F0Q36247044-9298490A-B950-4EFF-835C-666EB23D1884Q36434826-24675430-830C-4A41-B4FE-41EA57280BB5Q36503300-75A34741-A608-4888-BB76-8BF604709575Q36547571-F0F855EE-0980-413D-8101-2CC74F664057Q36631465-C0B007F5-50E6-4731-AD11-6CC232B467BAQ36703835-72B52B3A-A6D8-4941-B64B-EC1034E2F41CQ36805845-66E286B5-5858-4A9D-80A5-0235D212A270Q36864992-1221E34F-D18F-425F-8ECF-CCCA6E959DC2
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ingenol mebutate gel for actinic keratosis.
@ast
Ingenol mebutate gel for actinic keratosis.
@en
Ingenol mebutate gel for actinic keratosis.
@nl
type
label
Ingenol mebutate gel for actinic keratosis.
@ast
Ingenol mebutate gel for actinic keratosis.
@en
Ingenol mebutate gel for actinic keratosis.
@nl
prefLabel
Ingenol mebutate gel for actinic keratosis.
@ast
Ingenol mebutate gel for actinic keratosis.
@en
Ingenol mebutate gel for actinic keratosis.
@nl
P2093
P356
P1476
Ingenol mebutate gel for actinic keratosis.
@en
P2093
Anita Melgaard
Brian Berman
Lawrence L Anderson
Mark Lebwohl
Neil Swanson
P304
P356
10.1056/NEJMOA1111170
P407
P577
2012-03-01T00:00:00Z